DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
Bloodhound Technologies created a SaaS (Software as a Service) delivery platform aimed at helping healthcare payers control fraud and waste through a real-time claims processing environment.
Sold in 2011 to Verisk Analytics, Bloodhound customers included commercial health plans, state Medicaid agencies, and third-party administrators (TPAs) focused on combatting healthcare fraud through an emphasis on real-time adjudication, transparency for all participants in the claims cycle, business intelligence, and increased auto-adjudication and processing efficiencies.
Website
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.